Literature DB >> 10737280

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

J A Heit1, M D Silverstein, D N Mohr, T M Petterson, W M O'Fallon, L J Melton.   

Abstract

BACKGROUND: Reported risk factors for venous thromboembolism (VTE) vary widely, and the magnitude and independence of each are uncertain.
OBJECTIVES: To identify independent risk factors for deep vein thrombosis and pulmonary embolism and to estimate the magnitude of risk for each. PATIENTS AND METHODS: We performed a population-based, nested, case-control study of 625 Olmsted County, Minnesota, patients with a first lifetime VTE diagnosed during the 15-year period from January 1, 1976, through December 31, 1990, and 625 Olmsted County patients without VTE. The 2 groups were matched on age, sex, calendar year, and medical record number.
RESULTS: Independent risk factors for VTE included surgery (odds ratio [OR], 21.7; 95% confidence interval [CI], 9.4-49.9), trauma (OR, 12.7; 95% CI, 4.1-39.7), hospital or nursing home confinement (OR, 8.0; 95% CI, 4.5-14.2), malignant neoplasm with (OR, 6.5; 95% CI, 2.1-20.2) or without (OR, 4.1; 95% CI, 1.9-8.5) chemotherapy, central venous catheter or pacemaker (OR, 5.6; 95% CI, 1.6-19.6), superficial vein thrombosis (OR, 4.3; 95% CI, 1.8-10.6), and neurological disease with extremity paresis (OR, 3.0; 95% CI, 1.3-7.4). The risk associated with varicose veins diminished with age (for age 45 years: OR, 4.2; 95% CI, 1.6-11.3; for age 60 years: OR, 1.9; 95% CI, 1.0-3.6; for age 75 years: OR, 0.9; 95% CI, 0.6-1.4), while patients with liver disease had a reduced risk (OR, 0.1; 95% CI, 0.0-0.7).
CONCLUSION: Hospital or nursing home confinement, surgery, trauma, malignant neoplasm, chemotherapy, neurologic disease with paresis, central venous catheter or pacemaker, varicose veins, and superficial vein thrombosis are independent and important risk factors for VTE.

Entities:  

Mesh:

Year:  2000        PMID: 10737280     DOI: 10.1001/archinte.160.6.809

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  510 in total

1.  Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: a nested case-control study.

Authors:  Aneel A Ashrani; Marc D Silverstein; Thom W Rooke; Brian D Lahr; Tanya M Petterson; Kent R Bailey; L Joseph Melton; John A Heit
Journal:  Vasc Med       Date:  2010-10       Impact factor: 3.239

2.  Elevated plasma gas6 levels are associated with venous thromboembolic disease.

Authors:  Mark D Blostein; Isabelle Rajotte; Deepa P Rao; Christina A Holcroft; Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

3.  Androgen deprivation and thromboembolic events in men with prostate cancer.

Authors:  Behfar Ehdaie; Coral L Atoria; Amit Gupta; Andrew Feifer; William T Lowrance; Michael J Morris; Peter T Scardino; James A Eastham; Elena B Elkin
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

4.  Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis.

Authors:  Muhammad Ali; Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian
Journal:  Dig Dis Sci       Date:  2011-01-30       Impact factor: 3.199

5.  Variation in thromboembolic complications among patients undergoing commonly performed cancer operations.

Authors:  Randall R De Martino; Philip P Goodney; Emily L Spangler; Jessica B Wallaert; Matthew A Corriere; Eva M Rzucidlo; Daniel B Walsh; David H Stone
Journal:  J Vasc Surg       Date:  2012-03-10       Impact factor: 4.268

6.  Thromboembolic risk in the patient with heart failure.

Authors:  Liviu Klein; John B O'connell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

7.  Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients.

Authors:  E-M Reitter; C Ay; A Kaider; R Pirker; C Zielinski; G Zlabinger; I Pabinger
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

8.  Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle-invasive Bladder Cancer.

Authors:  Aditya Bagrodia; Ranjit Sukhu; Andrew G Winer; Eric Levy; Michael Vacchio; Byron Lee; Eugene J Pietzak; Timothy F Donahue; Eugene Cha; Gopa Iyer; Daniel D Sjoberg; Andrew J Vickers; Jonathan E Rosenberg; Dean F Bajorin; Guido Dalbagni; Bernard H Bochner
Journal:  Clin Genitourin Cancer       Date:  2017-08-10       Impact factor: 2.872

9.  A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Kathryn Lanuke; Lloyd A Mack; Walley J Temple
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

Review 10.  [Therapy and secondary prevention of venous thromboembolism with vitamin K antagonists].

Authors:  R M Bauersachs
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.